Skip to Main content Skip to Navigation
Journal articles

Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice

Héléna Mosbah 1, 2 Camille Vatier 1, 2 Franck Boccara 3, 1 Isabelle Jéru 4, 1 Olivier Lascols 1, 4 Marie-Christine Vantyghem 5, 6 Bruno Fève 1, 2 Bruno Donadille 1, 2 Elisabeth Sarrazin 7, 8 Sophie Benabbou 7, 8 Jocelyn Inamo 7, 8 Stephane Ederhy 3, 9 Ariel Cohen 3, 9 Barbara Neraud 10 Pascale Richard 11, 9, 12 Fabien Picard 13, 14 Sophie Christin-Maitre 2 Alban Redheuil 9, 15, 16, 17 Karim Wahbi 13, 14, 18 Corinne Vigouroux 1, 2, 4
Abstract : Variants in LMNA, encoding A-type lamins, are responsible for laminopathies including muscular dystrophies, lipodystrophies, and progeroid syndromes. Cardiovascular laminopathic involvement is classically described as cardiomyopathy in striated muscle laminopathies, and arterial wall dysfunction and/or valvulopathy in lipodystrophic and/or progeroid laminopathies. We report unexpected cardiovascular phenotypes in patients with LMNA-associated lipodystrophies, illustrating the complex multitissular pathophysiology of the disease and the need for specific cardiovascular investigations in affected patients. A 33-year-old woman was diagnosed with generalized lipodystrophy and atypical progeroid syndrome due to the newly identified heterozygous LMNA p.(Asp136Val) variant. Her complex cardiovascular phenotype was associated with atherosclerosis, aortic valvular disease and left ventricular hypertrophy with rhythm and conduction defects. A 29-year-old woman presented with a partial lipodystrophy syndrome and a severe coronary atherosclerosis which required a triple coronary artery bypass grafting. She carried the novel heterozygous p.(Arg60Pro) LMNA variant inherited from her mother, affected with partial lipodystrophy and dilated cardiomyopathy. Different lipodystrophy-associated LMNA pathogenic variants could target cardiac vasculature and/or muscle, leading to complex overlapping phenotypes. Unifying pathophysiological hypotheses should be explored in several cell models including adipocytes, cardiomyocytes and vascular cells. Patients with LMNA-associated lipodystrophy should be systematically investigated with 24-h ECG monitoring, echocardiography and non-invasive coronary function testing. View Full-Text
Document type :
Journal articles
Complete list of metadatas

Cited literature [59 references]  Display  Hide  Download
Contributor : Gestionnaire Hal-Su <>
Submitted on : Friday, May 15, 2020 - 10:59:45 AM
Last modification on : Tuesday, September 1, 2020 - 3:21:41 AM


Publication funded by an institution



Héléna Mosbah, Camille Vatier, Franck Boccara, Isabelle Jéru, Olivier Lascols, et al.. Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice. Cells 2020, 2020, 9 (3), pp.765. ⟨10.3390/cells9030765⟩. ⟨hal-02586223⟩



Record views


Files downloads